|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
31 August 2015 |
|
Main ID: |
NCT02531529 |
|
Date of registration:
|
20/08/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Dexmedetomedine Infusion Versus Fentanyl Infusion for Donor Anlgesia During Living Donor Hepatectomy
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
January 2014 |
|
Target sample size:
|
70 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02531529 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- donors of living donor liver transplantation
Exclusion Criteria:
- patient refusal Known allergy to dexmedetomedine
Age minimum:
20 Years
Age maximum:
40 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Donor Hepatectomy
|
|
Intervention(s)
|
|
Drug: dexmedetomedine
|
|
Drug: Fentanyl
|
|
Primary Outcome(s)
|
|
postoperative VAS scale
[Time Frame: 3 days]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|